Michael West new report, page-4

Another discussion to have is how litigation funding plays into the financing activities that relate to gross v net operating cashflow, which the author seems to infer that Shine are booking as revenue when it is not.

Is anyone aware of the distribution of risk in Shine’s litigation funding? Obviously the funding is used to pay disbursements whilst a case progresses, but the question is if the case is lost, is Shine, or the funder, the one that takes the hit on the disbursements? The answer to that would seemingly play a big part in determining how realistic it is to count the financing revenue as positive cashflow.